Taking a Closer Look At Gilead Sciences, Inc. (GILD) Following Its Recent Trade

Gilead Sciences, Inc.’s filing revealed that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.79 million. Then, Parsey Merdad sold 2,000 […]

Sharp increase in GILD’s short interest leads to surge in days-to-cover ratio

NUE

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares valued at $598,624 were sold by Parsey Merdad on Feb 29 ’24. At $72.74 per share, Parsey Merdad sold 8,230 shares. The insider’s holdings dropped to 92,706 […]

Gilead Sciences, Inc. [GILD] Insider Activity: An Update for Investors

Gilead Sciences, Inc.’s recently made public that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.96 million. Then, Parsey Merdad sold […]

Gilead Sciences, Inc. [NASDAQ: GILD] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $598,624 were sold by Parsey Merdad on Feb 29 ’24. At $72.74 per share, Parsey Merdad sold 8,230 shares. The insider’s holdings dropped to 92,706 shares worth approximately […]

Gilead Sciences, Inc. (GILD) may enjoy gains as insiders got busy in the recent days

Gilead Sciences, Inc.’s recent filing unveils that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.7 million. Then, Parsey Merdad sold 2,000 […]

Gilead Sciences, Inc. (GILD) rating downgrades by Truist

Gilead Sciences, Inc.’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $303.48 million. Then, GILEAD SCIENCES, INC. bought […]

Investing in Gilead Sciences, Inc. (GILD): What You Must Know

Gilead Sciences, Inc.’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $297.25 million. Then, GILEAD SCIENCES, INC. bought […]